Compare NEUP & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEUP | ACCL |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Hong Kong |
| Employees | 8 | 22 |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1M | 26.9M |
| IPO Year | N/A | N/A |
| Metric | NEUP | ACCL |
|---|---|---|
| Price | $3.88 | $2.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $21.00 | N/A |
| AVG Volume (30 Days) | ★ 206.9K | 24.4K |
| Earning Date | 05-23-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.19 | $1.23 |
| 52 Week High | $21.31 | $5.00 |
| Indicator | NEUP | ACCL |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 77.40 |
| Support Level | $3.91 | $1.31 |
| Resistance Level | $4.31 | $2.34 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 72.83 | 79.57 |
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.